HDGFL2 and malaria: The use of combination malaria RDTs (ie, combined HRP2 and pan-malarial parasite specific lactate dehydrogenase-based RDTs) will most likely reduce the challenge of false-negative cases, which is partially responsible for the lack of trust of RDTs among patients and caregivers in Nigeria.